| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | $1.6M | 0.00% | 46.02K | −11% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a CTEV trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 20, 2026 | Garis Douglas MichaelChief Financial Officer | Sale at price 30.50 - 31.19 per share. | 9K | $276.07K |
| Sep 13, 2026 | Letham Thomas BenjaminDirector | Stock Award(Grant) at price 0.00 per share. | 2.9K | — |
| Aug 27, 2026 | Dalton TravisChief Executive Officer | Purchase at price 38.48 - 38.81 per share. | 6.5K | $249.66K |
| Aug 13, 2026 | Misencik TiffaniOfficer | Sale at price 40.07 per share. | 8.8K | $354.59K |
| Aug 9, 2026 | Mintz William BOfficer | Sale at price 34.24 per share. | 8.4K | $288.68K |
| Jun 29, 2026 | Albinson BrockOfficer | Stock Award(Grant) at price 0.00 per share. | 3.6K | — |
| Jun 8, 2026 | Carol NutterOfficer | Purchase at price 28.41 per share. | 875 | $24.86K |
| May 18, 2026 | Prince John MichaelDirector | Purchase at price 16.00 per share. | 10K | $160.00K |
| May 17, 2026 | Kim MichaelOfficer | Purchase at price 16.65 per share. | 3K | $49.95K |
| May 17, 2026 | Dalton TravisChief Executive Officer | Purchase at price 16.42 per share. | 20.9K | $343.51K |
| Apr 28, 2026 | Klapstein Julie DDirector | Stock Award(Grant) at price 0.00 per share. | 9K | — |
| Apr 28, 2026 | Colaluca Anthony JrDirector | Stock Award(Grant) at price 0.00 per share. | 9K | — |
| Apr 28, 2026 | Klein Michael StuartDirector | Stock Award(Grant) at price 0.00 per share. | 9K | — |
| Apr 28, 2026 | Clarke Richard ADirector | Stock Award(Grant) at price 0.00 per share. | 9K | — |
| Apr 28, 2026 | Harris C. Martin M.D.Director | Stock Award(Grant) at price 0.00 per share. | 9K | — |
| Apr 28, 2026 | Prince John MichaelDirector | Stock Award(Grant) at price 0.00 per share. | 9K | — |
| Apr 28, 2026 | Kap Jason LamarDirector | Stock Award(Grant) at price 0.00 per share. | 9K | — |
| Mar 30, 2026 | Albinson BrockOfficer | Stock Award(Grant) at price 0.00 per share. | 3K | — |
| Mar 15, 2026 | Garis Douglas MichaelChief Financial Officer | Purchase at price 17.69 per share. | 1.3K | $23.00K |
| Mar 11, 2026 | Kim MichaelOfficer | Purchase at price 16.50 per share. | 15K | $247.50K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -36.5 | -50.4 | 21.3 | 48.9 | 3.2 | 35.8 | -33.4 | 75.4 | -46.8 | 13.8 | −43.7% | ||
| 2025 | 23.5 | 15.0 | -1.7 | 8.7 | 71.4 | 17.4 | -11.7 | 72.8 | -23.0 | 22.6 | -16.9 | -20.9 | +189.2% |
| 2024 | -29.9 | 10.9 | -27.6 | -19.9 | -17.4 | -27.7 | 16.0 | -47.8 | -18.7 | 17.3 | -11.9 | 87.3 | −74.3% |
| 2023 | 14.8 | -23.5 | 5.0 | -7.7 | 42.1 | 51.8 | 1.9 | -20.5 | -1.8 | 0.6 | -23.1 | 10.8 | +25.2% |
| 2022 | -9.0 | -6.7 | 24.5 | -5.3 | 12.9 | 9.8 | -7.8 | -30.4 | -18.8 | 0.3 | -48.1 | -22.8 | −74.0% |
| 2021 | -0.1 | -10.9 | -21.9 | 33.9 | 13.6 | 12.8 | -15.4 | -25.5 | -6.2 | -23.4 | -6.3 | 9.7 | −44.6% |
| 2020 | 3.0 | 5.3 | -4.0 | 11.2 | -11.0 | -28.8 | -4.9 | 15.1 | −19.7% |
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services. It also provides data and analytics solutions consists of PlanOptix, CompleteVue, BenInsights, risk scores, and supplemental carrier services. The company provides solutions to commercial healthcare payers, third party administrators, employers, brokers/consultants, providers, government healthcare payers and system integrators. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, property and casualty insurers, bill review companies and other companies involved in the claims adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in McLean, Virginia.
Buy / hold / sell counts